CPT Pearl of the Week
The Clinical Pharmacology and Toxicology (CPT) Pearls are short educational summaries of specific CPT topics. They are developed by physician members of the AHS Section of Clinical Pharmacology and Toxicology. The CPT pearls are not meant to be detailed management guidelines or comprehensive reviews.
The Pearls are grouped into the various categories on this page. These categories represent the breadth and depth of the specialty of CPT as well as the major objectives and core competencies of CPT training in Canada.
February 14, 2025 - Serum Sickness
February 5, 2025 - Causality Assessment Tools, Part III: WHO
January 31, 2025 - Causality Assessment Tools, Part II: Liverpool
January 22, 2025 - Causality Assessment Tools, Part I: Naranjo Scale
January 16, 2025 - Renal Drug Dosing Part II
January 10, 2025 - Renal Drug Dosing Part I
January 6, 2025 - Acetaminophen-Related Pyroglutamic Acidosis (PGA)
December 20, 2024 - Gamma Hydroxybutyrate (GHB)
December 13, 2024 - Drug Induced Liver Injury
December 9, 2024 - Alcohol Withdrawal
November 27, 2024 - Salicylate Poisoning
November 5, 2024 - Grapefruit Juice & Oral Medication Toxicity
October 30, 2024 - SCARs: Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)
October 18, 2024 - SCARs: Acute Generalized Exanthematous Pustulosis (AGEP)
October 15, 2024 - SCARs: Epidermal Necrolysis
September 17, 2024 - Drug Induced Lupus
September 5, 2024 - Acquired Methemoglobinemia
May 21, 2024 - Hydrogen Peroxide
March 21, 2024 - High Alert Medications
February 14, 2024 - Extravasation Injuries Part II
December 19, 2023 - Extravasation Injuries Part I
December 12, 2023 - Sugammadex
November 27, 2023 - Methotrexate Part II
October 31, 2023 - Tetracyclines in Pediatric Patients
September 14, 2023 - Drug Induced Brugada Syndrome
September 7, 2023 - Benzodiazepine Tapering
August 31, 2023 - P-glycoproteins
August 23, 2023 - Homeopathic Medicine
June 6, 2023 - Do Not Use Abbreviations
April 21, 2023 - Drug Induced Renal Tubular Acidosis
March 10, 2023 - Anabolic Steroids
January 31, 2023 - Pharmacovigilance
January 16, 2023 - Adverse Drug Reactions
December 19, 2022 - Flumazenil
December 5, 2022 - Extracorporeal Removal of Drugs
November 28, 2022 - Good Prescribing Practice
October 31, 2022 - Phenytoin Part 2
October 17, 2022 - Phenytoin Part 1
September 26, 2022 - Newer IV NAC Regimens Part 2
September 19, 2022 - Newer IV NAC Regimens Part 1
June 15, 2022 - Contrast Allergy
May 4, 2022 - IV NAC Neurotoxicity
February 25, 2022 - Drug Induced Movement Disorders
December 17, 2021 - Immune Checkpoint Inhibitors Part 1: Pharmacology and Indications
December 17, 2021 - Immune Checkpoint Inhibitors Part 2: Toxicity
December 17, 2021 - Immune Checkpoint Inhibitors Part 3: Management of Toxicity
November 16, 2021 - Statin Intolerance
October 18, 2021 - Carbon Monoxide (CO) Part 2: Testing and Treatment
October 12, 2021 - Carbon Monoxide (CO) Part 1: Sources and Symptoms
Drug Induced Alteration in Taste and Smell
Drug Induced Extrapyramidal Symptoms (EPS)
Drug Induced Urinary Retention
Medication Errors & Solutions: Part I
Medication Errors & Solutions: Part II
Medication Induced Hairy Tongue
Medication Safety Part 1: Appropriate Medication Prescribing
Medication Safety Part II: Deprescribing
Metformin Induced Hyperlactatemia
Propofol Related Infusion Syndrome
Restarting a Medication After an Adverse Event
Restarting a Medication After an Overdose